上海小方制药

Shanghai Xiaofang Pharmaceutical is a prominent Chinese pharmaceutical enterprise specializing in the development and manufacturing of over-the-counter (OTC) topical medications. Established in 1993 and headquartered in Shanghai, the company is widely recognized for its Daqing brand, which maintains a leading market position in several essential medicine categories. Its core product line includes glycerin enemas, calamine lotions, and various antiseptic solutions such as povidone-iodine and hydrogen peroxide. Xiaofang Pharmaceutical successfully listed on the Shanghai Stock Exchange in August 2024, marking a significant milestone in its corporate growth. The company operates advanced GMP-certified manufacturing facilities and focuses on providing high-quality, accessible dermatological and external-use healthcare products. Its extensive distribution network covers thousands of pharmacies and medical institutions across China.